To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene PIF1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
81 supporting clones for gene PIF1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AA093176   .f 778 to 1050 1 to 263   tiling clone, AAA   263/314
(83 %)
12 diff
(96.2 %id)
AB185926   .c 1 to 2687 1 to 2687 I640N tiling clone,   2687/2688
(99 %)
7 diff
(99.8 %id)
AB185927   .a 1 to 2278 1 to 2278 exact tiling clone,   2278/2279
(99 %)
2 diff
(100.0 %id)
AF108138   .d 1 to 1786 1 to 1786 I373N tiling clone, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 1786/1786
(100 %)
4 diff
(99.8 %id)
AK026345 human small intestine .e 1 to 1631 1 to 1631 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 1631/1631
(100 %)
2 diff
(99.9 %id)
AW801494 uterus .a 1534 to 1951 419 to 3       417/419
(99 %)
0 diff
(100 %id)
AY498716   .c 77 to 2682 1 to 2606 I640N tiling clone,   2606/2606
(100 %)
4 diff
(99.9 %id)
BC137503 Testicle, PCR rescued clones .c 63 to 2453 1 to 2391 exact tiling clone,   2391/2391
(100 %)
3 diff
(99.9 %id)
BC137504 Brain, cerebral cortex, PCR rescued clones .c 63 to 2453 1 to 2391 exact     2391/2391
(100 %)
3 diff
(99.9 %id)
TI_1971555299   .c 1422 to 2453 1105 to 72       1034/1316
(78 %)
12 diff
(99.1 %id)
TI_1971556307   .c 1179 to 2371 1194 to 11       1184/1280
(92 %)
22 diff
(98.3 %id)
TI_1971556321   .a 715 to 1859 19 to 1170       1152/1335
(86 %)
21 diff
(98.5 %id)
TI_1971556329   .c 1218 to 2383 22 to 1182       1161/1286
(90 %)
21 diff
(98.4 %id)
TI_1971558149   .a 60 to 652 48 to 639       592/639
(92 %)
6 diff
(99.1 %id)
BG951026 colon .l-u 112 to 721 27 to 632   tiling clone,   606/632
(95 %)
6 diff
(99.1 %id)
BM888249 eye .l-u 236 to 830 1 to 589 R41S L42W G43V A44Q A45P ...     589/589
(100 %)
12 diff
(98.0 %id)
BQ315498 epid_tumor .a 684 to 856 179 to 6       174/179
(97 %)
2 diff
(98.9 %id)
BX109827 liver and spleen .l-u 373 to 833 1 to 461 R24S AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 461/461
(100 %)
2 diff
(99.6 %id)
BX283578 choriocarcinoma, placenta .a 51 to 556 25 to 529       505/529
(95 %)
7 diff
(98.7 %id)
CN259034 embryonic stem cells, DMSO-treated H9 cellline .n-u 1 to 636 1 to 636 exact tiling clone,   636/636
(100 %)
3 diff
(99.6 %id)
CN259035 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 59 to 184 7 to 132       126/132
(95 %)
0 diff
(100 %id)
CN259036 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 83 to 355 1 to 273       273/273
(100 %)
1 diff
(99.7 %id)
CN259037 embryonic stem cells, cell lines H1, H7, andH9 .a 30 to 314 1 to 285       285/285
(100 %)
4 diff
(98.6 %id)
CN265097 embryonic stem cells, cell lines H1, H7, andH9 .a 931 to 1078 1 to 148       148/148
(100 %)
2 diff
(98.7 %id)
CN277199 embryonic stem cells, DMSO-treated H9 cellline .f 1068 to 1475 1 to 407   tiling clone,   407/407
(100 %)
2 diff
(99.6 %id)
CN358868 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1123 to 1822 1 to 701       701/701
(100 %)
2 diff
(99.8 %id)
CN358869 embryonic stem cells, cell lines H1, H7, andH9 .m 204 to 662 7 to 465 exact tiling clone,   459/465
(98 %)
6 diff
(98.8 %id)
CN358870 embryonic stem cells, cell lines H1, H7, andH9 .k 1 to 653 1 to 653   tiling clone,   653/653
(100 %)
2 diff
(99.7 %id)
CN358871 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 448 to 759 1 to 312 exact tiling clone,   312/312
(100 %)
0 diff
(100 %id)
CR738883 liver and spleen .l-u 373 to 833 1 to 461 R24S AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 461/461
(100 %)
2 diff
(99.6 %id)
DN930402 pooled .a 1408 to 1667 261 to 1     Submitted on the opposite strand 261/261
(100 %)
1 diff
(99.7 %id)
DQ437529   .c 96 to 2147 1 to 2052 exact     2052/2052
(100 %)
3 diff
(99.9 %id)
DW424379 Liver .m 1 to 268 22 to 289   tiling clone,   268/289
(92 %)
8 diff
(97.3 %id)
ES309570 occipital hair of pubic hypotrichosispatient, skin .a 1446 to 1910 19 to 471       453/555
(81 %)
17 diff
(97.0 %id)
EU084033   .b 1 to 2682 1 to 2682 exact tiling clone,   2682/2682
(100 %)
3 diff
(99.9 %id)
BP420945 small intestine .g 47 to 550 1 to 505     Submitted on the opposite strand 505/505
(100 %)
4 diff
(99.3 %id)
T54683 fetal spleen, Spleen .l-u 410 to 784 1 to 388 T57Y A58S R59*     388/392
(98 %)
22 diff
(94.4 %id)
T88870 liver and spleen .l-u 382 to 838 462 to 2 S12L F13L Q14S A15G A16C ...     461/464
(99 %)
0 diff
(100 %id)
W60651 heart .l-u 518 to 833 359 to 41   fully sequenced, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 319/319
(100 %)
2 diff
(99.4 %id)
W60880 heart .l-u 434 to 833 1 to 399 S46P K47N Q48R R49E T50R ... fully sequenced, Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 399/399
(100 %)
5 diff
(98.8 %id)
AA278838 germinal center B cell .l-u 479 to 838 363 to 3 A58G R59* tiling clone, fully sequenced,   361/363
(99 %)
0 diff
(100 %id)
AA279102 germinal center B cell .l-u 1 to 503 1 to 499   tiling clone, fully sequenced,   499/499
(100 %)
3 diff
(99.4 %id)
AA464521 ovarian tumor, ovary .c 1660 to 2168 1 to 492       492/495
(99 %)
21 diff
(95.8 %id)
AA464522 ovarian tumor, ovary .c 2253 to 2682 432 to 1       432/432
(100 %)
7 diff
(98.4 %id)
AA642924 epithelium (cell line), Prostate .a 2096 to 2273 194 to 17   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 178/179
(99 %)
0 diff
(100 %id)
AA743647 germinal center B cell .l-u 364 to 833 481 to 11 A58S R59* AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 471/471
(100 %)
2 diff
(99.6 %id)
AA872541 germinal center B cell .a 1998 to 2273 286 to 12   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 275/275
(100 %)
1 diff
(99.7 %id)
AA827755 germinal center B cell .a 318 to 787 1 to 467     Submitted on the opposite strand 467/467
(100 %)
17 diff
(96.4 %id)
AA973831 pooled germ cell tumors .f 1092 to 1376 294 to 11   tiling clone,   284/294
(96 %)
0 diff
(100 %id)
AI333976 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l-u 366 to 837 471 to 1 S12P Q14R A15L A16Q E17K ...     471/471
(100 %)
1 diff
(99.8 %id)
AI280491 ovary, tumor, 5 pooled (see description) .a 1962 to 2273 312 to 1       312/315
(99 %)
0 diff
(100 %id)
AI889087 colon, colon tumor, RER+ .a 101 to 294 194 to 1       194/194
(100 %)
2 diff
(99.0 %id)
AI654749 ovary, tumor, 5 pooled (see description) .l-u 417 to 833 417 to 1 S12P     417/417
(100 %)
2 diff
(99.6 %id)
AI745642 ovary, tumor, 5 pooled (see description) .l-u 438 to 834 397 to 1 exact     397/397
(100 %)
0 diff
(100 %id)
AI655645 pooled germ cell tumors .l-u 353 to 833 481 to 1 exact     481/481
(100 %)
0 diff
(100 %id)
AI696210 pooled germ cell tumors .a 1958 to 2273 315 to 1       315/315
(100 %)
1 diff
(99.7 %id)
AI827264 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2003 to 2273 286 to 16   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 271/271
(100 %)
3 diff
(98.9 %id)
AW004048 pooled germ cell tumors .l-u 283 to 833 562 to 12 exact AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 551/551
(100 %)
0 diff
(100 %id)
AI984536 colon, colonic mucosa from 3 patients with Crohn'sdisease .l-u 399 to 836 438 to 1 exact     438/438
(100 %)
1 diff
(99.8 %id)
AW170361 cervix, tumor .l-u 285 to 840 562 to 6 L52F S56F     557/562
(99 %)
0 diff
(100 %id)
AW590310 pooled germ cell tumors .l-u 341 to 837 497 to 1 exact     497/497
(100 %)
0 diff
(100 %id)
AW663962 pooled .l-u 359 to 834 477 to 2 G27A A58V     476/477
(99 %)
0 diff
(100 %id)
BF516453   .l-u 392 to 833 459 to 18 exact AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 442/442
(100 %)
1 diff
(99.8 %id)
CF137126 lymph .e 1129 to 1612 1 to 484       484/486
(99 %)
4 diff
(99.2 %id)
BC018978 Placenta, choriocarcinoma .f 1 to 1114 1 to 1114 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1114/1114
(100 %)
2 diff
(99.9 %id)
BE280562 choriocarcinoma, placenta .a 71 to 632 1 to 563   available from MGC,   563/563
(100 %)
7 diff
(98.8 %id)
BE387734 endometrium, adenocarcinoma cell line, uterus .e 990 to 1631 1 to 641   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 641/641
(100 %)
2 diff
(99.7 %id)
BF316643 brain, neuroblastoma .a 71 to 784 1 to 703       703/978
(71 %)
36 diff
(96.4 %id)
BG231673 blood, lymphocyte .l-u 349 to 832 484 to 1 exact     484/484
(100 %)
0 diff
(100 %id)
BG323851 Kidney, renal cell adenocarcinoma .a 122 to 744 1 to 624       624/624
(100 %)
26 diff
(95.9 %id)
BI116535 lung, small cell carcinoma .h 1 to 693 1 to 694 W155S R156E Q157A A158G D159R ... tiling clone,   694/695
(99 %)
7 diff
(99.0 %id)
BC033254 Prostate, carcinoma .g 2 to 1548 1 to 1547 I188N tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 1547/1547
(100 %)
1 diff
(100.0 %id)
BM043514 carcinoma, cell line, Prostate .g 1 to 644 1 to 646   tiling clone, available from MGC,   646/796
(81 %)
22 diff
(97.3 %id)
BQ061682 lymph, lymphoma, cell line .j 1 to 881 1 to 886 M12Y D13G S14Q N15Q E17* tiling clone,   886/971
(91 %)
17 diff
(98.3 %id)
BQ065272 lymph, lymphoma, cell line .j 1 to 670 1 to 673 exact tiling clone,   673/1188
(56 %)
9 diff
(99.3 %id)
BU502486 carcinoma, cell line, Prostate .g 23 to 568 90 to 641       552/1264
(43 %)
30 diff
(97.7 %id)
BQ958807 carcinoma, cell line, Prostate .g 3 to 811 1 to 820       820/876
(93 %)
13 diff
(98.6 %id)
NM_025049.2   .c 30 to 2688 1 to 2659 exact RefSeq,   2659/2659
(100 %)
1 diff
(100.0 %id)
DA997599   .a 426 to 813 2 to 389   capped   388/388
(100 %)
1 diff
(99.8 %id)
DN998093 breast cancer, Mammary gland (cancer tissue) .i 1 to 673 8 to 680 exact tiling clone,   673/680
(98 %)
6 diff
(99.2 %id)
DN999504   .a 65 to 630 12 to 577       566/577
(98 %)
6 diff
(99.0 %id)
TI_154166449   .e 1136 to 1632 93 to 590       498/953
(52 %)
5 diff
(99.5 %id)
CA310274 Alveolar Macrophage, lung .l-u 184 to 833 665 to 16 exact tiling clone, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 650/651
(99 %)
3 diff
(99.6 %id)
AI652391 pooled germ cell tumors .a 71 to 784 1 to 703     Suspected internal deletion, this clone was ignored 703/978
(71 %)
36 diff
(96.4 %id)
BF316643 brain, neuroblastoma .a 71 to 784 1 to 703       703/978
(71 %)
36 diff
(96.4 %id)
BG231673 blood, lymphocyte .l-u 349 to 832 484 to 1 exact     484/484
(100 %)
0 diff
(100 %id)
BG231673 blood, lymphocyte .l-u 349 to 832 484 to 1 exact     484/484
(100 %)
0 diff
(100 %id)
BG323851 Kidney, renal cell adenocarcinoma .a 122 to 744 1 to 624       624/624
(100 %)
26 diff
(95.9 %id)
BG323851 Kidney, renal cell adenocarcinoma .a 122 to 744 1 to 624       624/624
(100 %)
26 diff
(95.9 %id)
BI116535 lung, small cell carcinoma .h 1 to 693 1 to 694 W155S R156E Q157A A158G D159R ... tiling clone,   694/695
(99 %)
7 diff
(99.0 %id)
BI116535 lung, small cell carcinoma .h 1 to 693 1 to 694 W155S R156E Q157A A158G D159R ... tiling clone,   694/695
(99 %)
7 diff
(99.0 %id)
BC033254 Prostate, carcinoma .g 2 to 1548 1 to 1547 I188N tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 1547/1547
(100 %)
1 diff
(100.0 %id)
BM043514 carcinoma, cell line, Prostate .g 1 to 644 1 to 646   tiling clone, available from MGC,   646/796
(81 %)
22 diff
(97.3 %id)
BM043514 carcinoma, cell line, Prostate .g 1 to 644 1 to 646   tiling clone, available from MGC,   646/796
(81 %)
22 diff
(97.3 %id)
BQ061682 lymph, lymphoma, cell line .j 1 to 881 1 to 886 M12Y D13G S14Q N15Q E17* tiling clone,   886/971
(91 %)
17 diff
(98.3 %id)
BQ061682 lymph, lymphoma, cell line .j 1 to 881 1 to 886 M12Y D13G S14Q N15Q E17* tiling clone,   886/971
(91 %)
17 diff
(98.3 %id)
BQ065272 lymph, lymphoma, cell line .j 1 to 670 1 to 673 exact tiling clone,   673/1188
(56 %)
9 diff
(99.3 %id)
BQ065272 lymph, lymphoma, cell line .j 1 to 670 1 to 673 exact tiling clone,   673/1188
(56 %)
9 diff
(99.3 %id)
BU502486 carcinoma, cell line, Prostate .g 23 to 568 90 to 641       552/1264
(43 %)
30 diff
(97.7 %id)
BU502486 carcinoma, cell line, Prostate .g 23 to 568 90 to 641       552/1264
(43 %)
30 diff
(97.7 %id)
BQ958807 carcinoma, cell line, Prostate .g 3 to 811 1 to 820       820/876
(93 %)
13 diff
(98.6 %id)
BQ958807 carcinoma, cell line, Prostate .g 3 to 811 1 to 820       820/876
(93 %)
13 diff
(98.6 %id)
NM_025049.2   .c 30 to 2688 1 to 2659 exact RefSeq,   2659/2659
(100 %)
1 diff
(100.0 %id)
DA997599   .a 426 to 813 2 to 389   capped   388/388
(100 %)
1 diff
(99.8 %id)
DN998093 breast cancer, Mammary gland (cancer tissue) .i 1 to 673 8 to 680 exact tiling clone,   673/680
(98 %)
6 diff
(99.2 %id)
DN998093 breast cancer, Mammary gland (cancer tissue) .i 1 to 673 8 to 680 exact tiling clone,   673/680
(98 %)
6 diff
(99.2 %id)
DN999504   .a 65 to 630 12 to 577       566/577
(98 %)
6 diff
(99.0 %id)
TI_154166449   .e 1136 to 1632 93 to 590       498/953
(52 %)
5 diff
(99.5 %id)
CA310274 Alveolar Macrophage, lung .l-u 184 to 833 665 to 16 exact tiling clone, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 650/651
(99 %)
3 diff
(99.6 %id)
CA310274 Alveolar Macrophage, lung .l-u 184 to 833 665 to 16 exact tiling clone, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 650/651
(99 %)
3 diff
(99.6 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC